Some State Medicaid Programs Still Block or Limit Hep C Drugs

New article by Ed Silverman for Managed Care Magazine details that some states still limit hepatitis C treatment for Medicaid patients. “Restrictions blunted the effect of Sovaldi and other antivirals on Medicaid budgets. The gradual removal of these barriers is going too slowly, say advocates.”

Click here to read the full article.